These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

70 related items for PubMed ID: 9488040

  • 1. Growth-dependent and PKC-mediated translational regulation of the upstream stimulating factor-2 (USF2) mRNA in hematopoietic cells.
    Zhang ZC, Nechushtan H, Jacob-Hirsch J, Avni D, Meyuhas O, Razin E.
    Oncogene; 1998 Feb 12; 16(6):763-9. PubMed ID: 9488040
    [Abstract] [Full Text] [Related]

  • 2. Decreased tumorigenicity of c-Myc-transformed fibroblasts expressing active USF2.
    Choe C, Chen N, Sawadogo M.
    Exp Cell Res; 2005 Jan 01; 302(1):1-10. PubMed ID: 15541720
    [Abstract] [Full Text] [Related]

  • 3. Nuclear translocation of upstream stimulating factor 2 (USF2) in activated mast cells: a possible role in their survival.
    Frenkel S, Kay G, Nechushtan H, Razin E.
    J Immunol; 1998 Sep 15; 161(6):2881-7. PubMed ID: 9743349
    [Abstract] [Full Text] [Related]

  • 4. Mad1 expression in the absence of differentiation: effect of cAMP on the B-lymphoid cell line Reh.
    Naderi S, Blomhoff HK.
    J Cell Physiol; 1999 Jan 15; 178(1):76-84. PubMed ID: 9886493
    [Abstract] [Full Text] [Related]

  • 5. Upstream stimulatory factor (USF) as a transcriptional suppressor of human telomerase reverse transcriptase (hTERT) in oral cancer cells.
    Chang JT, Yang HT, Wang TC, Cheng AJ.
    Mol Carcinog; 2005 Nov 15; 44(3):183-92. PubMed ID: 16010690
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Constitutive c-myc expression enhances the response of murine mast cells to IL-3, but does not eliminate their requirement for growth factors.
    Hume CR, Nocka KH, Sorrentino V, Lee JS, Fleissner E.
    Oncogene; 1988 Mar 15; 2(3):223-6. PubMed ID: 3281092
    [Abstract] [Full Text] [Related]

  • 8. Expression of the microphthalmia-associated basic helix-loop-helix leucine zipper transcription factor Mi in avian neuroretina cells induces a pigmented phenotype.
    Planque N, Turque N, Opdecamp K, Bailly M, Martin P, Saule S.
    Cell Growth Differ; 1999 Jul 15; 10(7):525-36. PubMed ID: 10437920
    [Abstract] [Full Text] [Related]

  • 9. USF/c-Myc enhances, while Yin-Yang 1 suppresses, the promoter activity of CXCR4, a coreceptor for HIV-1 entry.
    Moriuchi M, Moriuchi H, Margolis DM, Fauci AS.
    J Immunol; 1999 May 15; 162(10):5986-92. PubMed ID: 10229837
    [Abstract] [Full Text] [Related]

  • 10. Loss of USF transcriptional activity in breast cancer cell lines.
    Ismail PM, Lu T, Sawadogo M.
    Oncogene; 1999 Sep 30; 18(40):5582-91. PubMed ID: 10523835
    [Abstract] [Full Text] [Related]

  • 11. Antiproliferative properties of the USF family of helix-loop-helix transcription factors.
    Luo X, Sawadogo M.
    Proc Natl Acad Sci U S A; 1996 Feb 06; 93(3):1308-13. PubMed ID: 8577760
    [Abstract] [Full Text] [Related]

  • 12. DNA binding of USF is required for specific E-box dependent gene activation in vivo.
    Kiermaier A, Gawn JM, Desbarats L, Saffrich R, Ansorge W, Farrell PJ, Eilers M, Packham G.
    Oncogene; 1999 Dec 02; 18(51):7200-11. PubMed ID: 10602473
    [Abstract] [Full Text] [Related]

  • 13. Tyrosine phosphorylation of Vav stimulates IL-6 production in mast cells by a Rac/c-Jun N-terminal kinase-dependent pathway.
    Song JS, Haleem-Smith H, Arudchandran R, Gomez J, Scott PM, Mill JF, Tan TH, Rivera J.
    J Immunol; 1999 Jul 15; 163(2):802-10. PubMed ID: 10395673
    [Abstract] [Full Text] [Related]

  • 14. Hepatocyte growth factor/scatter factor activates proliferation in melanoma cells through p38 MAPK, ATF-2 and cyclin D1.
    Recio JA, Merlino G.
    Oncogene; 2002 Feb 07; 21(7):1000-8. PubMed ID: 11850817
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of Kit expression by IL-4 and IL-10 in murine mast cells: role of STAT6 and phosphatidylinositol 3'-kinase.
    Mirmonsef P, Shelburne CP, Fitzhugh Yeatman C, Chong HJ, Ryan JJ.
    J Immunol; 1999 Sep 01; 163(5):2530-9. PubMed ID: 10452990
    [Abstract] [Full Text] [Related]

  • 16. Low molecular weight inhibitors of Myc-Max interaction and function.
    Yin X, Giap C, Lazo JS, Prochownik EV.
    Oncogene; 2003 Sep 18; 22(40):6151-9. PubMed ID: 13679853
    [Abstract] [Full Text] [Related]

  • 17. Differential effects of the widely expressed dMax splice variant of Max on E-box vs initiator element-mediated regulation by c-Myc.
    FitzGerald MJ, Arsura M, Bellas RE, Yang W, Wu M, Chin L, Mann KK, DePinho RA, Sonenshein GE.
    Oncogene; 1999 Apr 15; 18(15):2489-98. PubMed ID: 10229200
    [Abstract] [Full Text] [Related]

  • 18. Specific induction of RGS16 (regulator of G-protein signalling 16) mRNA by protein kinase C in CEM leukaemia cells is mediated via tumour necrosis factor alpha in a calcium-sensitive manner.
    Fong CW, Zhang Y, Neo SY, Lin SC.
    Biochem J; 2000 Dec 15; 352 Pt 3(Pt 3):747-53. PubMed ID: 11104682
    [Abstract] [Full Text] [Related]

  • 19. Isolation and initial characterization of the BRCA2 promoter.
    Davis PL, Miron A, Andersen LM, Iglehart JD, Marks JR.
    Oncogene; 1999 Oct 28; 18(44):6000-12. PubMed ID: 10557089
    [Abstract] [Full Text] [Related]

  • 20. A role for Id-1 in the aggressive phenotype and steroid hormone response of human breast cancer cells.
    Lin CQ, Singh J, Murata K, Itahana Y, Parrinello S, Liang SH, Gillett CE, Campisi J, Desprez PY.
    Cancer Res; 2000 Mar 01; 60(5):1332-40. PubMed ID: 10728695
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.